Published in Adv Perit Dial on January 01, 2008
Clinical causes of inflammation in peritoneal dialysis patients. Int J Nephrol (2014) 0.77
Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med (2003) 5.01
Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci (1995) 4.83
Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol (2002) 3.33
Neovasculature induced by vascular endothelial growth factor is fenestrated. Cancer Res (1997) 2.61
Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol (1998) 1.70
Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis. Perit Dial Int (2000) 1.44
Pathophysiology of peritoneal membrane failure. Perit Dial Int (2000) 1.38
What really happens to people on long-term peritoneal dialysis? Kidney Int (1998) 1.37
Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis. Nephrol Dial Transplant (1996) 1.37
Longitudinal relationship between solute transport and ultrafiltration capacity in peritoneal dialysis patients. Kidney Int (2004) 1.36
Plasma levels of IL-1 beta, TNF alpha and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients. Kidney Int (1994) 1.36
Host microvasculature influence on tumor vascular morphology and endothelial gene expression. Am J Pathol (1998) 1.31
Functional longevity of the human peritoneum: how long is continuous peritoneal dialysis possible? Results of a prospective medium long-term study. Am J Kidney Dis (1994) 1.30
Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate. Nephrol Dial Transplant (2002) 1.24
Morphological changes in the peritoneal vasculature of patients on CAPD with ultrafiltration failure. Nephron (1996) 1.18
Preparation of rat intestinal muscle and mucosa for quantitative microcirculatory studies. Microvasc Res (1976) 1.08
High volume, low frequency continuous ambulatory peritoneal dialysis. Kidney Int (1983) 1.06
Atlas of peritoneal histology. Perit Dial Int (2000) 1.05
Hyperosmolality, acetate, and lactate: dilatory factors during peritoneal dialysis. Kidney Int (1981) 1.04
Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration. Nephrol Dial Transplant (1999) 1.03
Peritoneal sclerosis in peritoneal dialysis patients related to dialysis settings and peritoneal transport properties. Kidney Int Suppl (2001) 1.00
Hemodynamic effects of peritoneal dialysis solutions on the rat peritoneal membrane: role of acidity, buffer choice, glucose concentration, and glucose degradation products. J Am Soc Nephrol (2002) 1.00
Generalized dilation of the visceral microvasculature by peritoneal dialysis solutions. Perit Dial Int (2002) 0.94
Association between an increased surface area of peritoneal microvessels and a high peritoneal solute transport rate. Perit Dial Int (2003) 0.92
Morphology of the peritoneal membrane during continuous ambulatory peritoneal dialysis. Nephron (1986) 0.91
Biocompatibility of peritoneal dialysis fluids: long-term exposure of nonuremic rats. Perit Dial Int (2004) 0.88
Experimental models in peritoneal dialysis: a European experience. Kidney Int (1998) 0.87
Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH. Nephrol Dial Transplant (2005) 0.87
Pressure threshold for fluid loss from the peritoneal cavity. Am J Physiol (1996) 0.86
Structural and functional alterations of the peritoneum after prolonged exposure to dialysis solutions: role of aminoguanidine. Perit Dial Int (2001) 0.85
Effect of peritoneal dialysis fluid measured in vivo in a rat-model of continuous peritoneal dialysis. Adv Perit Dial (1998) 0.85
Influence of neutral-pH dialysis solutions on the peritoneal membrane: a long-term investigation in rats. Perit Dial Int (2001) 0.84
Peritoneal dialysis solutions and the microcirculation. Contrib Nephrol (1979) 0.84
Effect of glucose degradation products on the peritoneal membrane in a chronic inflammatory infusion model of peritoneal dialysis in the rat. Perit Dial Int (2004) 0.83
Glucose suppresses peritoneal inflammatory reactions and mesothelial hyperplasia caused by intraperitoneal saline infusion. Adv Perit Dial (2002) 0.83
Disparity in osmolarity-induced vascular reactivity. J Am Soc Nephrol (2005) 0.82
Lymphatic versus nonlymphatic fluid absorption from the peritoneal cavity as related to the peritoneal ultrafiltration capacity and sieving properties. Blood Purif (1992) 0.81
Effects of vasodilators and peritoneal dialysis solution on the microcirculation of the rat cecum. Proc Soc Exp Biol Med (1979) 0.80
Intravital intestinal videomicroscopy: techniques and experiences. Microsurgery (2005) 0.80
A comparison of the biocompatibility of phosphate-buffered saline and dianeal 3.86% in the rat model of peritoneal dialysis. Adv Perit Dial (2001) 0.80
Enhanced peritoneal diffusion capacity of 51Cr-EDTA during the initial phase of peritoneal dialysis dwells: role of vasodilatation, dialysate 'stirring', and of interstitial factors. Blood Purif (1998) 0.79
Effects of acidity, glucose degradation products, and dialysis fluid buffer choice on peritoneal solute and fluid transport in rats. Perit Dial Int (1998) 0.79
Pathophysiological description of the ultrastructural changes of the peritoneal membrane during long-term continuous ambulatory peritoneal dialysis. Blood Purif (1994) 0.79
Peritoneal functional parameters after five years on continuous ambulatory peritoneal dialysis (CAPD): the effect of late peritonitis. Perit Dial Int (1989) 0.79
Comparison of the biocompatibility of phosphate-buffered saline alone, phosphate-buffered saline supplemented with glucose, and dianeal 3.86%. Perit Dial Int (2001) 0.78
Net ultrafiltration in peritoneal dialysis: role of direct fluid absorption into peritoneal tissue. Blood Purif (1992) 0.78
Electron microscopic alterations of the rat's pleura after experimental haemothorax. Ann Anat (2004) 0.78
Morphologic aspects of chronic peritoneal dialysis in a rat model. Perit Dial Int (2001) 0.78
Hypertonicity of dialysis fluid suppresses intraperitoneal inflammation. Adv Perit Dial (2000) 0.78
Characterization of an animal model of continuous peritoneal dialysis in chronic renal impairment. Clin Nephrol (1992) 0.77
Biologic significance of reduced levels of glucose degradation products. Perit Dial Int (2001) 0.76
Poor validity of residual volumes as a marker for risk of aspiration in critically ill patients. Crit Care Med (2005) 1.37
Obesity, inflammation, and the potential application of pharmaconutrition. Nutr Clin Pract (2008) 1.20
A novel method of peritoneal resuscitation improves organ perfusion after hemorrhagic shock. Am J Surg (2003) 0.98
Intraperitoneal resuscitation improves intestinal blood flow following hemorrhagic shock. Ann Surg (2003) 0.96
Mechanisms of direct peritoneal resuscitation-mediated splanchnic hyperperfusion following hemorrhagic shock. Shock (2007) 0.90
Altered intestinal microcirculation is the critical event in the development of necrotizing enterocolitis. J Pediatr Surg (2011) 0.85
Cellular edema regulates tissue capillary perfusion after hemorrhage resuscitation. Surgery (2007) 0.85
Leptin-based adjuvants: an innovative approach to improve vaccine response. Vaccine (2013) 0.84
Modulation of mesenteric lymph flow and composition by direct peritoneal resuscitation from hemorrhagic shock. Arch Surg (2009) 0.83
Postresuscitation tissue neutrophil infiltration is time-dependent and organ-specific. J Surg Res (2007) 0.83
Obesity-induced hepatic hypoperfusion primes for hepatic dysfunction after resuscitated hemorrhagic shock. Surgery (2009) 0.82
Hemorrhage-induced hepatic injury and hypoperfusion can be prevented by direct peritoneal resuscitation. J Gastrointest Surg (2009) 0.82
Ischaemic colitis associated with oral contraceptive and bisacodyl use. BMJ Case Rep (2012) 0.82
Maternal cigarette smoking and the development of necrotizing enterocolitis. Pediatrics (2012) 0.82
Tempol, an antioxidant, restores endothelium-derived hyperpolarizing factor-mediated vasodilation during hypertension. Eur J Pharmacol (2003) 0.80
Hemorrhagic shock and resuscitation-mediated tissue water distribution is normalized by adjunctive peritoneal resuscitation. J Am Coll Surg (2008) 0.80
Microvascular responses to adenosine help explain functional and pathologic differences between intestinal segments. Am J Surg (2004) 0.79
Direct peritoneal resuscitation accelerates primary abdominal wall closure after damage control surgery. J Am Coll Surg (2010) 0.79
Plasma appearance rate of intraperitoneal macromolecular tracer underestimates peritoneal lymph flow. Adv Perit Dial (2008) 0.78
Preservation of hepatic blood flow by direct peritoneal resuscitation improves survival and prevents hepatic inflammation following hemorrhagic shock. Am J Physiol Gastrointest Liver Physiol (2012) 0.78
Direct peritoneal resuscitation improves obesity-induced hepatic dysfunction after trauma. J Am Coll Surg (2012) 0.78
Clinical peritoneal dialysis solutions modulate white blood cell-intestinal vascular endothelium interaction. Am J Surg (2006) 0.78
The outcomes of obese patients in critical care. JPEN J Parenter Enteral Nutr (2011) 0.78
Clinical guidelines and nutrition therapy: better understanding and greater application to patient care. Crit Care Clin (2010) 0.77
Adjunctive treatment of abdominal catastrophes and sepsis with direct peritoneal resuscitation: indications for use in acute care surgery. J Trauma Acute Care Surg (2014) 0.77
Vasoactive components of dialysis solution. Perit Dial Int (2008) 0.76
Obesity and inflammation: II. Curr Gastroenterol Rep (2007) 0.76
Physician-delivered malnutrition: why do patients receive nothing by mouth or a clear liquid diet in a university hospital setting? JPEN J Parenter Enteral Nutr (2011) 0.76
Obesity and inflammation: III. Curr Gastroenterol Rep (2007) 0.76
Role of adenosine receptor subtypes in rat jejunum in unfed state versus glucose-induced hyperemia. J Surg Res (2007) 0.75
Two rare forms of hepatocellular carcinoma metastases. BMJ Case Rep (2013) 0.75
Obesity and inflammation: should the principles of immunonutrition be applied to this disease process? Curr Gastroenterol Rep (2007) 0.75
Nutrition therapy of the severely obese, critically ill patient: summation of conclusions and recommendations. JPEN J Parenter Enteral Nutr (2011) 0.75
Direct peritoneal resuscitation augments ileal blood flow in necrotizing enterocolitis via a novel mechanism. J Pediatr Surg (2012) 0.75
Hypoalbuminemia and Clinical Outcomes: What is the Mechanism behind the Relationship? Am Surg (2017) 0.75
Immune-enhancing diet and cytokine expression during chronic sepsis: an immune-enhancing diet containing L-arginine, fish oil, and RNA fragments promotes intestinal cytokine expression during chronic sepsis in rats. J Gastrointest Surg (2006) 0.75
Fish oil increases blood flow in the ileum during chronic feeding in rats. Nutr Res (2012) 0.75
Enteral glutamine supplementation impairs intestinal blood flow in rats. Am J Surg (2008) 0.75
Intestinal microcirculatory flow alterations in necrotizing enterocolitis are improved by direct peritoneal resuscitation. Am Surg (2012) 0.75
Adrenomedullin is increased in the portal circulation during chronic sepsis in rats. Am J Surg (2003) 0.75
Immune-enhancing enteral diet increases blood flow and proinflammatory cytokines in the rat ileum. J Surg Res (2003) 0.75
Immune-enhancing enteral diet selectively augments ileal blood flow in the rat. J Surg Res (2002) 0.75
How hyperalimentation may be necessary to reverse severe malnutrition in selected patients receiving home parenteral nutrition. Nutr Clin Pract (2014) 0.75
Contributing Editor's Note. Nutr Clin Pract (2017) 0.75
Intraperitoneal 1.5% Delflex improves intestinal blood flow in necrotizing enterocolitis. J Surg Res (2013) 0.75
Physician nutrition education. Nutr Clin Pract (2014) 0.75
The pharmacologic treatment of short bowel syndrome: new tricks and novel agents. Curr Gastroenterol Rep (2014) 0.75
Editor's Note. Nutr Clin Pract (2019) 0.75